TRI 3.70% 2.6¢ trivarx ltd

Ann: Medibio Quarterly Update and Cashflow Report, page-82

  1. 1,226 Posts.
    lightbulb Created with Sketch. 86
    "This has enabled us to i) re-commence the Depressive Burden trial; and ii) explore avenues for commercialisation of MEBsleep, in anticipation of FDA clearance."

    This sentence tells all, FDA approval should be this week.
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.